JP2005508875A - 転座因子として使用するためのペプチド - Google Patents
転座因子として使用するためのペプチド Download PDFInfo
- Publication number
- JP2005508875A JP2005508875A JP2003508978A JP2003508978A JP2005508875A JP 2005508875 A JP2005508875 A JP 2005508875A JP 2003508978 A JP2003508978 A JP 2003508978A JP 2003508978 A JP2003508978 A JP 2003508978A JP 2005508875 A JP2005508875 A JP 2005508875A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- conjugate
- amino acid
- deposit number
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005945 translocation Effects 0.000 title claims abstract description 37
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 48
- 102000004196 processed proteins & peptides Human genes 0.000 title description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 186
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 169
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims description 50
- 239000003814 drug Substances 0.000 claims description 45
- 230000001225 therapeutic effect Effects 0.000 claims description 22
- 229940124597 therapeutic agent Drugs 0.000 claims description 20
- 210000000170 cell membrane Anatomy 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 17
- 201000010099 disease Diseases 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 239000000032 diagnostic agent Substances 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 108700020796 Oncogene Proteins 0.000 claims description 8
- 108020001507 fusion proteins Proteins 0.000 claims description 8
- 102000037865 fusion proteins Human genes 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 5
- 229940039227 diagnostic agent Drugs 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 4
- 230000014616 translation Effects 0.000 claims description 4
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 claims description 3
- 239000002872 contrast media Substances 0.000 claims description 3
- 230000007812 deficiency Effects 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 102000040430 polynucleotide Human genes 0.000 claims description 3
- 108091033319 polynucleotide Proteins 0.000 claims description 3
- 239000002157 polynucleotide Substances 0.000 claims description 3
- 102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 claims description 2
- 101150053046 MYD88 gene Proteins 0.000 claims description 2
- 102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 claims description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims description 2
- 230000008238 biochemical pathway Effects 0.000 claims description 2
- 230000004071 biological effect Effects 0.000 claims description 2
- 230000001086 cytosolic effect Effects 0.000 claims description 2
- 230000008482 dysregulation Effects 0.000 claims description 2
- 230000004853 protein function Effects 0.000 claims description 2
- 101000852483 Homo sapiens Interleukin-1 receptor-associated kinase 1 Proteins 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 abstract description 6
- 108020004707 nucleic acids Proteins 0.000 abstract description 6
- 150000007523 nucleic acids Chemical class 0.000 abstract description 6
- 235000018102 proteins Nutrition 0.000 description 150
- 239000002243 precursor Substances 0.000 description 44
- 239000000427 antigen Substances 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 108010033040 Histones Proteins 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 108010005774 beta-Galactosidase Proteins 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 102100026189 Beta-galactosidase Human genes 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102100030385 Granzyme B Human genes 0.000 description 8
- 101001009603 Homo sapiens Granzyme B Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000001415 gene therapy Methods 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 230000033616 DNA repair Effects 0.000 description 7
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 7
- 102100030690 Histone H2B type 1-C/E/F/G/I Human genes 0.000 description 7
- 102000006947 Histones Human genes 0.000 description 7
- 101001084682 Homo sapiens Histone H2B type 1-C/E/F/G/I Proteins 0.000 description 7
- 102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 230000003834 intracellular effect Effects 0.000 description 7
- 102100031885 General transcription and DNA repair factor IIH helicase subunit XPB Human genes 0.000 description 6
- 101710198638 General transcription and DNA repair factor IIH helicase subunit XPB Proteins 0.000 description 6
- 101710110357 Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- 102100036514 Amyloid-beta A4 precursor protein-binding family A member 1 Human genes 0.000 description 5
- 101710093637 Amyloid-beta A4 precursor protein-binding family A member 1 Proteins 0.000 description 5
- 102100036441 Amyloid-beta A4 precursor protein-binding family A member 2 Human genes 0.000 description 5
- 101710093616 Amyloid-beta A4 precursor protein-binding family A member 2 Proteins 0.000 description 5
- 108090000560 Matrix metalloproteinase-15 Proteins 0.000 description 5
- 102100039477 Melanoma-associated antigen B1 Human genes 0.000 description 5
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 5
- 206010048218 Xeroderma Diseases 0.000 description 5
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 5
- 206010021198 ichthyosis Diseases 0.000 description 5
- 102000005162 pleiotrophin Human genes 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 108700031308 Antennapedia Homeodomain Proteins 0.000 description 4
- 102100021257 Beta-secretase 1 Human genes 0.000 description 4
- 101710150192 Beta-secretase 1 Proteins 0.000 description 4
- 102100026549 Caspase-10 Human genes 0.000 description 4
- 101001023028 Gallus gallus Myogenin Proteins 0.000 description 4
- 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 4
- 101000871966 Homo sapiens Histone H2B type 2-E Proteins 0.000 description 4
- 101001036688 Homo sapiens Melanoma-associated antigen B1 Proteins 0.000 description 4
- 101000666382 Homo sapiens Transcription factor E2-alpha Proteins 0.000 description 4
- 102100036186 Importin subunit alpha-5 Human genes 0.000 description 4
- 102000004043 Matrix metalloproteinase-15 Human genes 0.000 description 4
- 102100039479 Melanoma-associated antigen B2 Human genes 0.000 description 4
- 102000043276 Oncogene Human genes 0.000 description 4
- 102100038950 Proprotein convertase subtilisin/kexin type 7 Human genes 0.000 description 4
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 4
- 102000014105 Semaphorin Human genes 0.000 description 4
- 108050003978 Semaphorin Proteins 0.000 description 4
- 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 4
- 102100029823 Tyrosine-protein kinase BTK Human genes 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 238000009256 replacement therapy Methods 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 3
- 102100024156 Cadherin-12 Human genes 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- 102100025682 Dystroglycan 1 Human genes 0.000 description 3
- 108010071885 Dystroglycans Proteins 0.000 description 3
- 102100037354 Ectodysplasin-A Human genes 0.000 description 3
- 102100038595 Estrogen receptor Human genes 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 102100031249 H/ACA ribonucleoprotein complex subunit DKC1 Human genes 0.000 description 3
- 101001036686 Homo sapiens Melanoma-associated antigen B2 Proteins 0.000 description 3
- 101000878253 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 3
- 101710118220 Importin subunit alpha-5 Proteins 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 102100025211 Mitogen-activated protein kinase kinase kinase 14 Human genes 0.000 description 3
- 102100021970 Myc box-dependent-interacting protein 1 Human genes 0.000 description 3
- 108010026626 Neuroendocrine Secretory Protein 7B2 Proteins 0.000 description 3
- 102100036248 Neuroendocrine protein 7B2 Human genes 0.000 description 3
- 102100038550 Neurogenin-1 Human genes 0.000 description 3
- 101710096136 Neurogenin-1 Proteins 0.000 description 3
- 102100025929 Neuronal migration protein doublecortin Human genes 0.000 description 3
- 102100023059 Nuclear factor NF-kappa-B p100 subunit Human genes 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108090000445 Parathyroid hormone Proteins 0.000 description 3
- 102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 description 3
- 102100037419 Pituitary tumor-transforming gene 1 protein-interacting protein Human genes 0.000 description 3
- 101710199379 Pituitary tumor-transforming gene 1 protein-interacting protein Proteins 0.000 description 3
- 102100036142 Polycystin-2 Human genes 0.000 description 3
- 101710180647 Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 3
- 101700032040 SMAD1 Proteins 0.000 description 3
- 102100036831 Steroid hormone receptor ERR2 Human genes 0.000 description 3
- 102100034924 T-lymphocyte activation antigen CD86 Human genes 0.000 description 3
- 102100038313 Transcription factor E2-alpha Human genes 0.000 description 3
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 3
- 102100030737 Transforming growth factor beta-2 proprotein Human genes 0.000 description 3
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 3
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 description 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
- 108010073925 Vascular Endothelial Growth Factor B Proteins 0.000 description 3
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 3
- 102100038217 Vascular endothelial growth factor B Human genes 0.000 description 3
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 210000000933 neural crest Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- CORXEUSRKLNMDW-UHFFFAOYSA-N 3-[[1-(2,5-dioxopyrrolidin-1-yl)-2h-pyridin-2-yl]disulfanyl]propanoic acid Chemical compound OC(=O)CCSSC1C=CC=CN1N1C(=O)CCC1=O CORXEUSRKLNMDW-UHFFFAOYSA-N 0.000 description 2
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 description 2
- 102100038778 Amphiregulin Human genes 0.000 description 2
- 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 description 2
- 108020004491 Antisense DNA Proteins 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 description 2
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 2
- 101710178010 Baculoviral IAP repeat-containing protein 5 Proteins 0.000 description 2
- 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 2
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102100031168 CCN family member 2 Human genes 0.000 description 2
- 102100022527 Cadherin-18 Human genes 0.000 description 2
- 102100035037 Calpastatin Human genes 0.000 description 2
- 102100034744 Cell division cycle 7-related protein kinase Human genes 0.000 description 2
- 101710183997 Cell division cycle 7-related protein kinase Proteins 0.000 description 2
- 206010053138 Congenital aplastic anaemia Diseases 0.000 description 2
- 108010039419 Connective Tissue Growth Factor Proteins 0.000 description 2
- 108050005899 Core histone macro-H2A Proteins 0.000 description 2
- 102000017634 Core histone macro-H2A Human genes 0.000 description 2
- 101710163109 Cylicin-1 Proteins 0.000 description 2
- 102100036233 Cylicin-1 Human genes 0.000 description 2
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 2
- 108010069091 Dystrophin Proteins 0.000 description 2
- 102000001039 Dystrophin Human genes 0.000 description 2
- 102100031855 Estrogen-related receptor gamma Human genes 0.000 description 2
- 102100026059 Exosome complex component RRP45 Human genes 0.000 description 2
- 101710120484 Exosome complex component RRP45 Proteins 0.000 description 2
- 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 2
- 108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 2
- 108010074860 Factor Xa Proteins 0.000 description 2
- 201000004939 Fanconi anemia Diseases 0.000 description 2
- 102000001398 Granzyme Human genes 0.000 description 2
- 108060005986 Granzyme Proteins 0.000 description 2
- 108010041881 Growth Differentiation Factor 10 Proteins 0.000 description 2
- 101710194458 Growth/differentiation factor 10 Proteins 0.000 description 2
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
- 101710167047 H/ACA ribonucleoprotein complex subunit DKC1 Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 102100021544 Histone H2B type 1-O Human genes 0.000 description 2
- 102100033572 Histone H2B type 2-E Human genes 0.000 description 2
- 101000762238 Homo sapiens Cadherin-12 Proteins 0.000 description 2
- 101000983518 Homo sapiens Caspase-10 Proteins 0.000 description 2
- 101100120531 Homo sapiens FOS gene Proteins 0.000 description 2
- 101000898881 Homo sapiens Histone H2B type 1-O Proteins 0.000 description 2
- 101000835862 Homo sapiens Mothers against decapentaplegic homolog 1 Proteins 0.000 description 2
- 101000979338 Homo sapiens Nuclear factor NF-kappa-B p100 subunit Proteins 0.000 description 2
- 101001074439 Homo sapiens Polycystin-2 Proteins 0.000 description 2
- 101000931462 Homo sapiens Protein FosB Proteins 0.000 description 2
- 101000946850 Homo sapiens T-lymphocyte activation antigen CD86 Proteins 0.000 description 2
- 101000635958 Homo sapiens Transforming growth factor beta-2 proprotein Proteins 0.000 description 2
- 101000830600 Homo sapiens Tumor necrosis factor ligand superfamily member 13 Proteins 0.000 description 2
- 102000001284 I-kappa-B kinase Human genes 0.000 description 2
- 108060006678 I-kappa-B kinase Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102100040019 Interferon alpha-1/13 Human genes 0.000 description 2
- 102000004344 Interferon regulatory factor 2 Human genes 0.000 description 2
- 108090000908 Interferon regulatory factor 2 Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 102100033246 Lysine-specific demethylase 5A Human genes 0.000 description 2
- 102100030201 Matrix metalloproteinase-15 Human genes 0.000 description 2
- 102100037020 Melanoma antigen preferentially expressed in tumors Human genes 0.000 description 2
- 108050000748 Melanoma-associated antigen D1 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 2
- 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 2
- 101710084102 Mitogen-activated protein kinase kinase kinase 14 Proteins 0.000 description 2
- 102100034670 Myb-related protein B Human genes 0.000 description 2
- 101710115153 Myb-related protein B Proteins 0.000 description 2
- 101710146921 Myc box-dependent-interacting protein 1 Proteins 0.000 description 2
- 102100032970 Myogenin Human genes 0.000 description 2
- 101710173606 NK-tumor recognition protein Proteins 0.000 description 2
- 102100023384 NK-tumor recognition protein Human genes 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 2
- 108050000588 Neurogenic differentiation factor 1 Proteins 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 101710105341 Neuronal migration protein doublecortin Proteins 0.000 description 2
- 108010047956 Nucleosomes Proteins 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 101710123753 Parathyroid hormone-related protein Proteins 0.000 description 2
- 101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 2
- 101710205202 Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 102100039277 Pleiotrophin Human genes 0.000 description 2
- 102100020847 Protein FosB Human genes 0.000 description 2
- 101710149951 Protein Tat Proteins 0.000 description 2
- 102100027584 Protein c-Fos Human genes 0.000 description 2
- 102100038152 RNA-binding protein 5 Human genes 0.000 description 2
- 101710133259 RNA-binding protein 5 Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000007506 Retinoblastoma-Binding Protein 1 Human genes 0.000 description 2
- 108010071012 Retinoblastoma-Binding Protein 1 Proteins 0.000 description 2
- 108010071010 Retinoblastoma-Binding Protein 2 Proteins 0.000 description 2
- 102100039120 Retinoblastoma-like protein 1 Human genes 0.000 description 2
- 108050006676 Retinoblastoma-related proteins Proteins 0.000 description 2
- 102100039758 Serine/threonine-protein kinase DCLK1 Human genes 0.000 description 2
- 101710096799 Serine/threonine-protein kinase DCLK1 Proteins 0.000 description 2
- 102100036832 Steroid hormone receptor ERR1 Human genes 0.000 description 2
- 108010062276 T-Cell Acute Lymphocytic Leukemia Protein 1 Proteins 0.000 description 2
- 102000002154 T-Lymphoma Invasion and Metastasis-inducing Protein 1 Human genes 0.000 description 2
- 108010001288 T-Lymphoma Invasion and Metastasis-inducing Protein 1 Proteins 0.000 description 2
- 102100037906 T-cell surface glycoprotein CD3 zeta chain Human genes 0.000 description 2
- 101710156660 T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 description 2
- 102100034928 T-cell surface glycoprotein CD8 beta chain Human genes 0.000 description 2
- 101710192266 Tegument protein VP22 Proteins 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102100023132 Transcription factor Jun Human genes 0.000 description 2
- 102100027654 Transcription factor PU.1 Human genes 0.000 description 2
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 2
- 102100031638 Tuberin Human genes 0.000 description 2
- 108010065323 Tumor Necrosis Factor Ligand Superfamily Member 13 Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 2
- 101710187882 Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 2
- 101710098624 Tyrosine-protein kinase ABL1 Proteins 0.000 description 2
- 101710086214 Tyrosine-protein kinase BTK Proteins 0.000 description 2
- 108010075653 Utrophin Proteins 0.000 description 2
- 102000011856 Utrophin Human genes 0.000 description 2
- 102100029092 Utrophin Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 102100038144 Wiskott-Aldrich syndrome protein family member 1 Human genes 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000009175 antibody therapy Methods 0.000 description 2
- 239000003816 antisense DNA Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 108010044208 calpastatin Proteins 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- -1 cationic lipid Chemical class 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108091008559 estrogen-related receptor alpha Proteins 0.000 description 2
- 108091008558 estrogen-related receptor beta Proteins 0.000 description 2
- 108020004067 estrogen-related receptors Proteins 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000018276 interleukin-1 production Effects 0.000 description 2
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000001623 nucleosome Anatomy 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 201000008543 xeroderma pigmentosum group B Diseases 0.000 description 2
- 201000008551 xeroderma pigmentosum group C Diseases 0.000 description 2
- 201000008559 xeroderma pigmentosum group F Diseases 0.000 description 2
- XJOTXKZIRSHZQV-RXHOOSIZSA-N (3S)-3-amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(1R,6R,12R,17R,20S,23S,26R,31R,34R,39R,42S,45S,48S,51S,59S)-51-(4-aminobutyl)-31-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]-20-benzyl-23-[(2S)-butan-2-yl]-45-(3-carbamimidamidopropyl)-48-(hydroxymethyl)-42-(1H-imidazol-4-ylmethyl)-59-(2-methylsulfanylethyl)-7,10,19,22,25,33,40,43,46,49,52,54,57,60,63,64-hexadecaoxo-3,4,14,15,28,29,36,37-octathia-8,11,18,21,24,32,41,44,47,50,53,55,58,61,62,65-hexadecazatetracyclo[32.19.8.26,17.212,39]pentahexacontan-26-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)[C@@H](C)O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1cnc[nH]1)NC3=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N2)C(=O)NCC(=O)N4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XJOTXKZIRSHZQV-RXHOOSIZSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- BUOYTFVLNZIELF-UHFFFAOYSA-N 2-phenyl-1h-indole-4,6-dicarboximidamide Chemical compound N1C2=CC(C(=N)N)=CC(C(N)=N)=C2C=C1C1=CC=CC=C1 BUOYTFVLNZIELF-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 108700005241 ATP Binding Cassette Transporter 1 Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
- 102100032601 Adhesion G protein-coupled receptor B2 Human genes 0.000 description 1
- 101710096307 Adhesion G protein-coupled receptor B2 Proteins 0.000 description 1
- 102100036775 Afadin Human genes 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108010033760 Amphiregulin Proteins 0.000 description 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 1
- 102000014303 Amyloid beta-Protein Precursor Human genes 0.000 description 1
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
- 102100030762 Apolipoprotein L1 Human genes 0.000 description 1
- 101000869034 Arabidopsis thaliana H/ACA ribonucleoprotein complex subunit 4 Proteins 0.000 description 1
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
- UKGGPJNBONZZCM-WDSKDSINSA-N Asp-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 1
- 101710082739 Aspartic protease 2 Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 102100036465 Autoimmune regulator Human genes 0.000 description 1
- 108010021800 B7-2 Antigen Proteins 0.000 description 1
- 102000007697 B7-2 Antigen Human genes 0.000 description 1
- 102100037135 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Human genes 0.000 description 1
- 101710204705 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Proteins 0.000 description 1
- 102100033943 Basic salivary proline-rich protein 2 Human genes 0.000 description 1
- 102100035631 Bloom syndrome protein Human genes 0.000 description 1
- 108091009167 Bloom syndrome protein Proteins 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 101100237637 Bos taurus APOL gene Proteins 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 101710196882 Cadherin-12 Proteins 0.000 description 1
- 101710196875 Cadherin-15 Proteins 0.000 description 1
- 101710196880 Cadherin-18 Proteins 0.000 description 1
- 229940121926 Calpain inhibitor Drugs 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100025632 Caspase recruitment domain-containing protein 18 Human genes 0.000 description 1
- 108090000572 Caspase-10 Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100034528 Core histone macro-H2A.1 Human genes 0.000 description 1
- 101710184999 Core histone macro-H2A.1 Proteins 0.000 description 1
- 102100038114 Cyclin-dependent kinase 13 Human genes 0.000 description 1
- 101710179317 Cyclin-dependent kinase 13 Proteins 0.000 description 1
- 102100033234 Cyclin-dependent kinase 17 Human genes 0.000 description 1
- 101710179321 Cyclin-dependent kinase 17 Proteins 0.000 description 1
- 101710084687 Cyclin-dependent kinase 2 homolog Proteins 0.000 description 1
- 102100024257 Cylicin-2 Human genes 0.000 description 1
- 101710163112 Cylicin-2 Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108010076525 DNA Repair Enzymes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102100033195 DNA ligase 4 Human genes 0.000 description 1
- 102100029094 DNA repair endonuclease XPF Human genes 0.000 description 1
- 101710155004 DNA repair endonuclease XPF Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102100039886 DNA-directed RNA polymerase III subunit RPC4 Human genes 0.000 description 1
- 102000010170 Death domains Human genes 0.000 description 1
- 108050001718 Death domains Proteins 0.000 description 1
- 101710092028 Density-regulated protein Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 101800001224 Disintegrin Proteins 0.000 description 1
- 102100040844 Dual specificity protein kinase CLK2 Human genes 0.000 description 1
- 102100029211 E3 ubiquitin-protein ligase TTC3 Human genes 0.000 description 1
- 101710148712 E3 ubiquitin-protein ligase TTC3 Proteins 0.000 description 1
- 101710126243 Ectodysplasin-A Proteins 0.000 description 1
- 108010072589 Ectodysplasins Proteins 0.000 description 1
- 102100037074 Ellis-van Creveld syndrome protein Human genes 0.000 description 1
- 101710199605 Endoribonuclease Proteins 0.000 description 1
- 102400000686 Endothelin-1 Human genes 0.000 description 1
- 101800004490 Endothelin-1 Proteins 0.000 description 1
- 108090000387 Endothelin-2 Proteins 0.000 description 1
- 102000003965 Endothelin-2 Human genes 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 108010085330 Estradiol Receptors Proteins 0.000 description 1
- 101710196141 Estrogen receptor Proteins 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 101710103508 FK506-binding protein Proteins 0.000 description 1
- 101710104425 FK506-binding protein 2 Proteins 0.000 description 1
- 101710104423 FK506-binding protein 3 Proteins 0.000 description 1
- 101710104333 FK506-binding protein 4 Proteins 0.000 description 1
- 101710104342 FK506-binding protein 5 Proteins 0.000 description 1
- 101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 description 1
- DSIFMINXCSHZPQ-UHFFFAOYSA-M FUN-1 Chemical compound [I-].S1C2=CC=CC=C2[N+](C)=C1C=C(C1=CC=CC=C11)C=C(Cl)N1C1=CC=CC=C1 DSIFMINXCSHZPQ-UHFFFAOYSA-M 0.000 description 1
- 201000006107 Familial adenomatous polyposis Diseases 0.000 description 1
- 102100023360 Forkhead box protein N2 Human genes 0.000 description 1
- 102100023372 Fos-related antigen 1 Human genes 0.000 description 1
- 108090000123 Fos-related antigen 1 Proteins 0.000 description 1
- 102100028121 Fos-related antigen 2 Human genes 0.000 description 1
- 108090000641 Fos-related antigen 2 Proteins 0.000 description 1
- 102100036336 Fragile X mental retardation syndrome-related protein 2 Human genes 0.000 description 1
- 101710118680 Fragile X mental retardation syndrome-related protein 2 Proteins 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- 102100034316 Gem-associated protein 2 Human genes 0.000 description 1
- 108050002004 Gem-associated protein 2 Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 102100033417 Glucocorticoid receptor Human genes 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 1
- 101710204282 Growth/differentiation factor 5 Proteins 0.000 description 1
- 108050006583 Growth/differentiation factor 8 Proteins 0.000 description 1
- 102100040408 Heat shock 70 kDa protein 1-like Human genes 0.000 description 1
- 102100028515 Heat shock-related 70 kDa protein 2 Human genes 0.000 description 1
- 101710191109 Heat shock-related 70 kDa protein 2 Proteins 0.000 description 1
- 102000013950 Hepatic leukemia factor Human genes 0.000 description 1
- 108050003766 Hepatic leukemia factor Proteins 0.000 description 1
- 102100036284 Hepcidin Human genes 0.000 description 1
- 102400001150 Hepcidin-20 Human genes 0.000 description 1
- 101800003308 Hepcidin-20 Proteins 0.000 description 1
- 108010024124 Histone Deacetylase 1 Proteins 0.000 description 1
- 102100037487 Histone H1.0 Human genes 0.000 description 1
- 101710103716 Histone H1A Proteins 0.000 description 1
- 101710103714 Histone H1B Proteins 0.000 description 1
- 101710103720 Histone H1C Proteins 0.000 description 1
- 102000017286 Histone H2A Human genes 0.000 description 1
- 108050005231 Histone H2A Proteins 0.000 description 1
- 101710195517 Histone H2AX Proteins 0.000 description 1
- 102100030687 Histone H2B type 1-B Human genes 0.000 description 1
- 102100030650 Histone H2B type 1-H Human genes 0.000 description 1
- 102100030649 Histone H2B type 1-J Human genes 0.000 description 1
- 102100021640 Histone H2B type 1-L Human genes 0.000 description 1
- 102100021637 Histone H2B type 1-M Human genes 0.000 description 1
- 102100021638 Histone H2B type 1-N Human genes 0.000 description 1
- 102100039846 Histone H2B type F-M Human genes 0.000 description 1
- 102100033071 Histone acetyltransferase KAT6A Human genes 0.000 description 1
- 102100039996 Histone deacetylase 1 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100323521 Homo sapiens APOL1 gene Proteins 0.000 description 1
- 101000928246 Homo sapiens Afadin Proteins 0.000 description 1
- 101000809450 Homo sapiens Amphiregulin Proteins 0.000 description 1
- 101000928549 Homo sapiens Autoimmune regulator Proteins 0.000 description 1
- 101001125486 Homo sapiens Basic salivary proline-rich protein 1 Proteins 0.000 description 1
- 101001068639 Homo sapiens Basic salivary proline-rich protein 2 Proteins 0.000 description 1
- 101000933105 Homo sapiens Caspase recruitment domain-containing protein 18 Proteins 0.000 description 1
- 101001044612 Homo sapiens Density-regulated protein Proteins 0.000 description 1
- 101000749291 Homo sapiens Dual specificity protein kinase CLK2 Proteins 0.000 description 1
- 101000909218 Homo sapiens Dynamin-1-like protein Proteins 0.000 description 1
- 101000880080 Homo sapiens Ectodysplasin-A Proteins 0.000 description 1
- 101000881890 Homo sapiens Ellis-van Creveld syndrome protein Proteins 0.000 description 1
- 101000920831 Homo sapiens Estrogen-related receptor gamma Proteins 0.000 description 1
- 101000907593 Homo sapiens Forkhead box protein N2 Proteins 0.000 description 1
- 101000844866 Homo sapiens H/ACA ribonucleoprotein complex subunit DKC1 Proteins 0.000 description 1
- 101001037977 Homo sapiens Heat shock 70 kDa protein 1-like Proteins 0.000 description 1
- 101001021253 Homo sapiens Hepcidin Proteins 0.000 description 1
- 101001026554 Homo sapiens Histone H1.0 Proteins 0.000 description 1
- 101001084691 Homo sapiens Histone H2B type 1-B Proteins 0.000 description 1
- 101001084676 Homo sapiens Histone H2B type 1-H Proteins 0.000 description 1
- 101001084678 Homo sapiens Histone H2B type 1-J Proteins 0.000 description 1
- 101000898901 Homo sapiens Histone H2B type 1-L Proteins 0.000 description 1
- 101000898894 Homo sapiens Histone H2B type 1-M Proteins 0.000 description 1
- 101000898897 Homo sapiens Histone H2B type 1-N Proteins 0.000 description 1
- 101001035373 Homo sapiens Histone H2B type F-M Proteins 0.000 description 1
- 101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
- 101000944179 Homo sapiens Histone acetyltransferase KAT6A Proteins 0.000 description 1
- 101001001462 Homo sapiens Importin subunit alpha-5 Proteins 0.000 description 1
- 101000878213 Homo sapiens Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Proteins 0.000 description 1
- 101000944277 Homo sapiens Inward rectifier potassium channel 2 Proteins 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- 101000573901 Homo sapiens Major prion protein Proteins 0.000 description 1
- 101001011884 Homo sapiens Matrix metalloproteinase-15 Proteins 0.000 description 1
- 101001095088 Homo sapiens Melanoma antigen preferentially expressed in tumors Proteins 0.000 description 1
- 101001027925 Homo sapiens Metastasis-associated protein MTA1 Proteins 0.000 description 1
- 101000970561 Homo sapiens Myc box-dependent-interacting protein 1 Proteins 0.000 description 1
- 101001023043 Homo sapiens Myoblast determination protein 1 Proteins 0.000 description 1
- 101000589002 Homo sapiens Myogenin Proteins 0.000 description 1
- 101000720704 Homo sapiens Neuronal migration protein doublecortin Proteins 0.000 description 1
- 101100252621 Homo sapiens POLR3D gene Proteins 0.000 description 1
- 101100137533 Homo sapiens PRAME gene Proteins 0.000 description 1
- 101001098872 Homo sapiens Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 1
- 101000912957 Homo sapiens Protein DEK Proteins 0.000 description 1
- 101000743272 Homo sapiens RNA-binding protein 5 Proteins 0.000 description 1
- 101000851696 Homo sapiens Steroid hormone receptor ERR2 Proteins 0.000 description 1
- 101000946833 Homo sapiens T-cell surface glycoprotein CD8 beta chain Proteins 0.000 description 1
- 101000596772 Homo sapiens Transcription factor 7-like 1 Proteins 0.000 description 1
- 101000830568 Homo sapiens Tumor necrosis factor alpha-induced protein 2 Proteins 0.000 description 1
- 101000823316 Homo sapiens Tyrosine-protein kinase ABL1 Proteins 0.000 description 1
- 101000911513 Homo sapiens Uncharacterized protein FAM215A Proteins 0.000 description 1
- 101000841301 Homo sapiens Utrophin Proteins 0.000 description 1
- 101000743137 Homo sapiens Wiskott-Aldrich syndrome protein family member 1 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010016648 Immunophilins Proteins 0.000 description 1
- 102000000521 Immunophilins Human genes 0.000 description 1
- 102100035692 Importin subunit alpha-1 Human genes 0.000 description 1
- 102100036984 Inactive peptidyl-prolyl cis-trans isomerase FKBP6 Human genes 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 101710192051 Interferon alpha-1/13 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
- 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
- 101710199015 Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102100033114 Inward rectifier potassium channel 2 Human genes 0.000 description 1
- 108010000837 Janus Kinase 1 Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 102100025818 Major prion protein Human genes 0.000 description 1
- 101710179150 Melanoma-associated antigen B1 Proteins 0.000 description 1
- 108700035584 Melanoma-associated antigen B2 Proteins 0.000 description 1
- 102000008835 Melanoma-associated antigen D1 Human genes 0.000 description 1
- 102100027247 Melanoma-associated antigen D1 Human genes 0.000 description 1
- 102100027256 Melanoma-associated antigen H1 Human genes 0.000 description 1
- 101710178947 Melanoma-associated antigen H1 Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108700021154 Metallothionein 3 Proteins 0.000 description 1
- 102100028708 Metallothionein-3 Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 102100037517 Metastasis-associated protein MTA1 Human genes 0.000 description 1
- 101100333722 Mus musculus Ercc5 gene Proteins 0.000 description 1
- 102100034711 Myb-related protein A Human genes 0.000 description 1
- 101710115158 Myb-related protein A Proteins 0.000 description 1
- 102100035077 Myoblast determination protein 1 Human genes 0.000 description 1
- 102100038380 Myogenic factor 5 Human genes 0.000 description 1
- 102100038379 Myogenic factor 6 Human genes 0.000 description 1
- 108010056785 Myogenin Proteins 0.000 description 1
- 108010056852 Myostatin Proteins 0.000 description 1
- 108010014632 NF-kappa B kinase Proteins 0.000 description 1
- 102100023031 Neural Wiskott-Aldrich syndrome protein Human genes 0.000 description 1
- 102100032062 Neurogenic differentiation factor 2 Human genes 0.000 description 1
- 108050000625 Neurogenic differentiation factor 2 Proteins 0.000 description 1
- 108010009519 Neuronal Wiskott-Aldrich Syndrome Protein Proteins 0.000 description 1
- 101100025373 Notophthalmus viridescens MYF-5 gene Proteins 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 101710180962 Nuclear factor NF-kappa-B p100 subunit Proteins 0.000 description 1
- 101800003567 Nuclear factor NF-kappa-B p49 subunit Proteins 0.000 description 1
- 108010027206 Nucleopolyhedrovirus inhibitor of apoptosis Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 102100025062 Nucleosome-remodeling factor subunit BPTF Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 101710114693 Outer membrane protein MIP Proteins 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 206010068786 Overlap syndrome Diseases 0.000 description 1
- 102100036893 Parathyroid hormone Human genes 0.000 description 1
- 102000043299 Parathyroid hormone-related Human genes 0.000 description 1
- 102100036899 Parathyroid hormone-related protein Human genes 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710111213 Peptidyl-prolyl cis-trans isomerase D Proteins 0.000 description 1
- 102100037827 Peptidyl-prolyl cis-trans isomerase D Human genes 0.000 description 1
- 101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 1
- 101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 description 1
- 101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 description 1
- 101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 1
- 101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
- 101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 description 1
- 101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 description 1
- 101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 description 1
- 101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 description 1
- 101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 description 1
- 101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 description 1
- 101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 description 1
- 101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 description 1
- 101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 description 1
- 101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 description 1
- 101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 description 1
- 101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 description 1
- 101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 description 1
- 101710146368 Polycystin-2 Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 102100025803 Progesterone receptor Human genes 0.000 description 1
- 108010044159 Proprotein Convertases Proteins 0.000 description 1
- 102000006437 Proprotein Convertases Human genes 0.000 description 1
- 102100026113 Protein DEK Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 208000008425 Protein deficiency Diseases 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 102100024260 Protocadherin alpha-3 Human genes 0.000 description 1
- 101710167873 Protocadherin alpha-3 Proteins 0.000 description 1
- 101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 101000961289 Rattus norvegicus Ankyrin repeat and SAM domain-containing protein 6 Proteins 0.000 description 1
- 102000018779 Replication Protein C Human genes 0.000 description 1
- 108010027647 Replication Protein C Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 108010002342 Retinoblastoma-Like Protein p107 Proteins 0.000 description 1
- 108010003494 Retinoblastoma-Like Protein p130 Proteins 0.000 description 1
- 102000004642 Retinoblastoma-Like Protein p130 Human genes 0.000 description 1
- 102000008935 SMN Complex Proteins Human genes 0.000 description 1
- 108010049037 SMN Complex Proteins Proteins 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 102100027974 Semaphorin-3A Human genes 0.000 description 1
- 108010090319 Semaphorin-3A Proteins 0.000 description 1
- 102100027979 Semaphorin-3B Human genes 0.000 description 1
- 101710199438 Semaphorin-3B Proteins 0.000 description 1
- 102100027980 Semaphorin-3C Human genes 0.000 description 1
- 101710199433 Semaphorin-3C Proteins 0.000 description 1
- 102100027746 Semaphorin-3D Human genes 0.000 description 1
- 101710199434 Semaphorin-3D Proteins 0.000 description 1
- 102100020824 Serine-protein kinase ATM Human genes 0.000 description 1
- 101710128348 Serine-protein kinase ATM Proteins 0.000 description 1
- 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
- 102100022978 Sex-determining region Y protein Human genes 0.000 description 1
- 101710188553 Sex-determining region Y protein Proteins 0.000 description 1
- 101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 1
- 102100029969 Ski oncogene Human genes 0.000 description 1
- 108050005312 Ski oncogene Proteins 0.000 description 1
- 102000004880 Spastin Human genes 0.000 description 1
- 108090001068 Spastin Proteins 0.000 description 1
- 102100028898 Striatin Human genes 0.000 description 1
- 229930189942 Striatin Natural products 0.000 description 1
- 101710175524 Striatin Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000011768 T-Cell Acute Lymphocytic Leukemia Protein 1 Human genes 0.000 description 1
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 1
- 102100040365 T-cell acute lymphocytic leukemia protein 1 Human genes 0.000 description 1
- 208000000389 T-cell leukemia Diseases 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- 206010042971 T-cell lymphoma Diseases 0.000 description 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- 101710204227 T-cell surface glycoprotein CD8 beta chain Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 101710179927 T-lymphocyte activation antigen CD86 Proteins 0.000 description 1
- 102100034107 TP53-binding protein 1 Human genes 0.000 description 1
- 101710156963 TP53-binding protein 1 Proteins 0.000 description 1
- 108010004408 TRPP Cation Channels Proteins 0.000 description 1
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 1
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 1
- 101000898914 Tetrahymena thermophila (strain SB210) Histone H2A.1 Proteins 0.000 description 1
- 102100031293 Thimet oligopeptidase Human genes 0.000 description 1
- 108060008245 Thrombospondin Proteins 0.000 description 1
- 102000002938 Thrombospondin Human genes 0.000 description 1
- 108010018242 Transcription Factor AP-1 Proteins 0.000 description 1
- 108050005223 Transcription factor Jun Proteins 0.000 description 1
- 101710145813 Transcription factor PU.1 Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102100032250 Trichohyalin Human genes 0.000 description 1
- 108050009309 Tuberin Proteins 0.000 description 1
- 108700019205 Tuberous Sclerosis Complex 2 Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 102000000504 Tumor Suppressor p53-Binding Protein 1 Human genes 0.000 description 1
- 108010041385 Tumor Suppressor p53-Binding Protein 1 Proteins 0.000 description 1
- 101710112793 Tyrosine-protein kinase JAK1 Proteins 0.000 description 1
- 102100026728 Uncharacterized protein FAM215A Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 102100027538 WAS/WASL-interacting protein family member 1 Human genes 0.000 description 1
- 101710148954 WAS/WASL-interacting protein family member 1 Proteins 0.000 description 1
- 101710201029 Wiskott-Aldrich syndrome protein family member 1 Proteins 0.000 description 1
- 102100037103 Wiskott-Aldrich syndrome protein family member 2 Human genes 0.000 description 1
- 101710201035 Wiskott-Aldrich syndrome protein family member 2 Proteins 0.000 description 1
- 102100037104 Wiskott-Aldrich syndrome protein family member 3 Human genes 0.000 description 1
- 101710201036 Wiskott-Aldrich syndrome protein family member 3 Proteins 0.000 description 1
- 101001034655 Xenopus laevis Insulin-like growth factor I-B Proteins 0.000 description 1
- 201000006083 Xeroderma Pigmentosum Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 102000004111 amphiphysin Human genes 0.000 description 1
- 108090000686 amphiphysin Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 108010079785 calpain inhibitors Proteins 0.000 description 1
- ZXJCOYBPXOBJMU-HSQGJUDPSA-N calpastatin peptide Ac 184-210 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(O)=O)NC(C)=O)[C@@H](C)O)C1=CC=C(O)C=C1 ZXJCOYBPXOBJMU-HSQGJUDPSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000004656 cell transport Effects 0.000 description 1
- 229950006687 cetermin Drugs 0.000 description 1
- 201000002797 childhood leukemia Diseases 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000562 conjugate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- MLFJHYIHIKEBTQ-IYRKOGFYSA-N endothelin 2 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CSSC[C@@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=3C4=CC=CC=C4NC=3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC1)C1=CNC=N1 MLFJHYIHIKEBTQ-IYRKOGFYSA-N 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 108091008557 estrogen-related receptor gamma Proteins 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 108010072251 fetal Alzheimer antigen Proteins 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 102000018511 hepcidin Human genes 0.000 description 1
- 108060003558 hepcidin Proteins 0.000 description 1
- 229940066919 hepcidin Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 108010064752 interleukin 1beta-converting enzyme 2 Proteins 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 108010011989 karyopherin alpha 2 Proteins 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 108010084677 myogenic factor 6 Proteins 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000032405 negative regulation of neuron apoptotic process Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 108010032563 oligopeptidase Proteins 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 208000005987 polymyositis Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108010028075 procathepsin L Proteins 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 108090000468 progesterone receptors Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108010020129 proprotein convertase PC7 Proteins 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108010008929 proto-oncogene protein Spi-1 Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 229940074386 skatole Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- MVDHBKXZWUGLAH-UHFFFAOYSA-N striatine Natural products CC(=CCc1c(O)ccc2C3COc4cc(O)c(cc4C3Oc12)C(C)(C)C=C)C MVDHBKXZWUGLAH-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 108010073106 thimet oligopeptidase Proteins 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 229940072041 transforming growth factor beta 2 Drugs 0.000 description 1
- 108010031667 trichohyalin Proteins 0.000 description 1
- SZCZSKMCTGEJKI-UHFFFAOYSA-N tuberin Natural products COC1=CC=C(C=CNC=O)C=C1 SZCZSKMCTGEJKI-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- 239000000225 tumor suppressor protein Substances 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 201000008558 xeroderma pigmentosum group G Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0116047.2A GB0116047D0 (en) | 2001-06-29 | 2001-06-29 | Peptide motif for therapy |
| PCT/GB2002/003027 WO2003002598A2 (en) | 2001-06-29 | 2002-07-01 | Peptides for use as translocation factors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508875A true JP2005508875A (ja) | 2005-04-07 |
| JP2005508875A5 JP2005508875A5 (enExample) | 2006-01-05 |
Family
ID=9917697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508978A Pending JP2005508875A (ja) | 2001-06-29 | 2002-07-01 | 転座因子として使用するためのペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040234527A1 (enExample) |
| EP (1) | EP1399570A2 (enExample) |
| JP (1) | JP2005508875A (enExample) |
| CA (1) | CA2451236A1 (enExample) |
| GB (1) | GB0116047D0 (enExample) |
| IL (1) | IL158742A0 (enExample) |
| WO (1) | WO2003002598A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200305980B (en) | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
| CA2454048C (en) | 2001-07-17 | 2011-05-03 | Research Development Foundation | Therapeutic agents comprising pro-apoptotic proteins |
| US7411048B2 (en) | 2002-11-19 | 2008-08-12 | Drg International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids |
| US8017737B2 (en) | 2002-11-19 | 2011-09-13 | Hasan Kulaksiz | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| EP1578254B1 (en) | 2002-11-19 | 2013-03-06 | DRG International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| US20050032173A1 (en) * | 2003-08-05 | 2005-02-10 | Mauricio Rojas | Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response |
| WO2007047907A2 (en) | 2005-10-14 | 2007-04-26 | The Regents Of The University Of Michigan | Dek protein compositions and methods of using the same |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993025197A1 (en) * | 1992-06-12 | 1993-12-23 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU741546B2 (en) * | 1997-07-24 | 2001-12-06 | Perseptive Biosystems, Inc. | Conjugates of transporter peptides and nucleic acid analogs, and their use |
| IL151910A0 (en) * | 2000-04-12 | 2003-04-10 | Implyx Ltd | Compositions for drug delivery |
| WO2002062823A2 (en) * | 2001-02-02 | 2002-08-15 | Yale University | Peptides for facilitating composite receptor expression and translocation of macromolecules |
-
2001
- 2001-06-29 GB GBGB0116047.2A patent/GB0116047D0/en not_active Ceased
-
2002
- 2002-07-01 WO PCT/GB2002/003027 patent/WO2003002598A2/en not_active Ceased
- 2002-07-01 EP EP02748992A patent/EP1399570A2/en not_active Withdrawn
- 2002-07-01 CA CA002451236A patent/CA2451236A1/en not_active Abandoned
- 2002-07-01 IL IL15874202A patent/IL158742A0/xx unknown
- 2002-07-01 US US10/479,166 patent/US20040234527A1/en not_active Abandoned
- 2002-07-01 JP JP2003508978A patent/JP2005508875A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993025197A1 (en) * | 1992-06-12 | 1993-12-23 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
Non-Patent Citations (2)
| Title |
|---|
| CANCER RES., vol. 58, no. 24, JPN6008027212, December 1999 (1999-12-01), pages 5686 - 5689, ISSN: 0001057919 * |
| PROC. NATL. ACAD. SCI. U.S.A., vol. 90, no. 7, JPN6008027210, April 1993 (1993-04-01), pages 2846 - 2850, ISSN: 0001057918 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1399570A2 (en) | 2004-03-24 |
| CA2451236A1 (en) | 2003-01-09 |
| WO2003002598A3 (en) | 2003-04-10 |
| US20040234527A1 (en) | 2004-11-25 |
| IL158742A0 (en) | 2004-05-12 |
| GB0116047D0 (en) | 2001-08-22 |
| WO2003002598A2 (en) | 2003-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220287968A1 (en) | Lipid vesicle-mediated delivery to cells | |
| US8354387B2 (en) | Methods and compositions for delivering siRNA into mammalian cells | |
| EP1408114B1 (de) | Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen | |
| JP2007535908A (ja) | 運搬ペプチド、活性物質を有するその構築物および用途 | |
| Beyersdorf et al. | Robust, durable gene activation in vivo via mRNA-encoded activators | |
| KR20190020299A (ko) | 면역 조정 폴리펩타이드를 암호화하는 mRNA의 조합물 및 이의 용도 | |
| EP4194001B1 (en) | Enterically delivered bitter oligopeptides for the treatment of type 2 diabetes and obesity | |
| CN109248310B (zh) | 利用θ-防御素的炎性蛋白酶的阻断 | |
| US20220265843A1 (en) | Extracellular vesicle-mediated delivery to cells | |
| JP7055455B2 (ja) | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 | |
| US20040213797A1 (en) | Conjugates for the modulation of immune responses | |
| AU4673901A (en) | Peptide conjugates for drug delivery | |
| US20100016221A1 (en) | Method of degrading protein by chaperone-mediated autophagy | |
| US20040234527A1 (en) | Peptides for use as translocation factors | |
| KR20190083237A (ko) | 세포 유래 엑소좀을 포함하는 핵산 전달용 조성물, 키트, 및 이를 이용한 방법 | |
| CN117836310A (zh) | 细胞穿透肽、抗癌肽和包括其的用于预防或治疗癌症的药物组合物 | |
| KR102206808B1 (ko) | 신규한 세포-투과 펩타이드 및 이를 포함하는 피부 개선용 조성물 | |
| US20230128981A1 (en) | Cd24-loaded vesicles for treatment of cytokine storm and other conditions | |
| US11771777B2 (en) | Three-dimensional self-assembled nucleic acid nanoparticles and use thereof | |
| AU2002319407A1 (en) | Peptides for use as translocation factors | |
| US20240254489A1 (en) | Compositions and methods of targeting the pax6 signaling pathway to reduce formation of amyloid beta plaques and neurofibrillary tangles | |
| KR20090092536A (ko) | 유전자 전달 효율이 개선된 재조합 아데노바이러스 및리포좀을 포함하는 조성물 | |
| KR20140022700A (ko) | 약물 전달체인 텔로머라제 펩티드를 포함하는 조성물 | |
| Brown et al. | Retroviruses and DNA: gene therapy for brain tumours | |
| US20060258601A1 (en) | Formulation for inwardly transferring nucleic acids into eucaryotic cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050701 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050701 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080603 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081125 |